By Izzy Wood (Drug Target Review)2023-07-27T16:00:57
US researchers say new mechanism could lead to new drugs and therapies to treat normal cognitive decline in aging.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-25T15:00:00Z 2026-03-25T16:00:00Z
Sponsored by Yokogawa and Danaher Life Sciences
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-02-23T14:02:18
Sponsored by bit.bio
2023-11-24T12:06:45
Sponsored by Quantum-Si
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa and Danaher Life Sciences
2024-01-26T13:22:42
Sponsored by bit.bio
Site powered by Webvision Cloud